[
  {
    "objectID": "quarto/index.html",
    "href": "quarto/index.html",
    "title": "Clinical Outcomes of MS in CVD",
    "section": "",
    "text": "Reference Papers:\n\nSidhu et al. 2022\n\nStudy Objective: Examine the impact of Multiple Sclerosis (MS) on in-hospital mortality and length of stay among inpatient admissions with a principal diagnosis of cerebrovascular (CVD)\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with a principal diagnosis of cerebrovascular disease.\nCVD + MS Categories:\n\nCVD with MS\nCVD without MS\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#preamble",
    "href": "quarto/index.html#preamble",
    "title": "Clinical Outcomes of MS in CVD",
    "section": "",
    "text": "Reference Papers:\n\nSidhu et al. 2022\n\nStudy Objective: Examine the impact of Multiple Sclerosis (MS) on in-hospital mortality and length of stay among inpatient admissions with a principal diagnosis of cerebrovascular (CVD)\nData Source: Cross-sectional analysis of the National Inpatient Sample (NIS) from 2018 to 2020.\nPatient Selection: Included all inpatient admissions with a principal diagnosis of cerebrovascular disease.\nCVD + MS Categories:\n\nCVD with MS\nCVD without MS\n\nPrimary Outcomes:\n\nIn-hospital all-cause mortality\nTotal hospital length of stay (days)\nTotal charge, inflation adjusted to 2020 ($)\n\nSoftware: All analyses were performed using R Version 4.4.1 (R Foundation for Statistical Computing, Vienna, Austria)"
  },
  {
    "objectID": "quarto/index.html#baseline-table",
    "href": "quarto/index.html#baseline-table",
    "title": "Clinical Outcomes of MS in CVD",
    "section": "Baseline Table:",
    "text": "Baseline Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall N = 2,697,2851\nCVD with MS N = 9,5351\nCVD without MS N = 2,687,7501\np-value2\n\n\n\n\nAge, y\n69 (14)\n63 (13)\n69 (14)\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n&lt;0.001\n\n\n    Female\n1,316,685 (49)\n6,815 (71)\n1,309,870 (49)\n\n\n\n\n    Male\n1,380,475 (51)\n2,720 (29)\n1,377,755 (51)\n\n\n\n\nRace\n\n\n\n\n\n\n&lt;0.001\n\n\n    White\n1,786,970 (68)\n7,000 (76)\n1,779,970 (68)\n\n\n\n\n    Asian or Pacific Islander\n86,710 (3.3)\n75 (0.8)\n86,635 (3.3)\n\n\n\n\n    Black\n434,350 (17)\n1,400 (15)\n432,950 (17)\n\n\n\n\n    Hispanic\n228,465 (8.7)\n510 (5.5)\n227,955 (8.7)\n\n\n\n\n    Native American\n13,260 (0.5)\n35 (0.4)\n13,225 (0.5)\n\n\n\n\n    Other\n72,975 (2.8)\n220 (2.4)\n72,755 (2.8)\n\n\n\n\nCharlson comorbidity index\n3.44 (2.08)\n3.16 (1.93)\n3.44 (2.08)\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n&lt;0.001\n\n\n    $1 - $51,999\n801,675 (30)\n2,390 (25)\n799,285 (30)\n\n\n\n\n    $52,000 - $65,999\n712,045 (27)\n2,605 (28)\n709,440 (27)\n\n\n\n\n    $66,000 - $87,999\n632,865 (24)\n2,480 (26)\n630,385 (24)\n\n\n\n\n    $88,000 or more\n507,880 (19)\n1,980 (21)\n505,900 (19)\n\n\n\n\nExpected primary payer\n\n\n\n\n\n\n0.052\n\n\n    Private\n645,795 (24)\n2,515 (26)\n643,280 (24)\n\n\n\n\n    Medicaid\n264,665 (9.8)\n985 (10)\n263,680 (9.8)\n\n\n\n\n    Medicare\n1,719,965 (64)\n5,795 (61)\n1,714,170 (64)\n\n\n\n\n    Other\n63,210 (2.3)\n210 (2.2)\n63,000 (2.3)\n\n\n\n\nHospital region\n\n\n\n\n\n\n&lt;0.001\n\n\n    Midwest\n593,715 (22)\n2,535 (27)\n591,180 (22)\n\n\n\n\n    Northeast\n461,440 (17)\n1,770 (19)\n459,670 (17)\n\n\n\n\n    South\n1,127,510 (42)\n3,460 (36)\n1,124,050 (42)\n\n\n\n\n    West\n514,620 (19)\n1,770 (19)\n512,850 (19)\n\n\n\n\nHospital bedsize\n\n\n\n\n\n\n0.91\n\n\n    Large\n1,493,355 (55)\n5,305 (56)\n1,488,050 (55)\n\n\n\n\n    Medium\n750,485 (28)\n2,610 (27)\n747,875 (28)\n\n\n\n\n    Small\n453,445 (17)\n1,620 (17)\n451,825 (17)\n\n\n\n\nHospital location and teaching status\n\n\n\n\n\n\n0.47\n\n\n    Rural\n169,170 (6.3)\n545 (5.7)\n168,625 (6.3)\n\n\n\n\n    Urban, non-teaching\n442,825 (16)\n1,510 (16)\n441,315 (16)\n\n\n\n\n    Urban, teaching\n2,085,290 (77)\n7,480 (78)\n2,077,810 (77)\n\n\n\n\nHypertension\n2,261,495 (84)\n7,310 (77)\n2,254,185 (84)\n&lt;0.001\n\n\nDiabetes mellitus\n1,001,335 (37)\n3,000 (31)\n998,335 (37)\n&lt;0.001\n\n\nPeripheral vascular disease\n261,900 (9.7)\n725 (7.6)\n261,175 (9.7)\n0.003\n\n\nHeart failure\n464,830 (17)\n1,045 (11)\n463,785 (17)\n&lt;0.001\n\n\nCOPD\n453,720 (17)\n1,710 (18)\n452,010 (17)\n0.19\n\n\nChronic kidney disease\n493,095 (18)\n1,115 (12)\n491,980 (18)\n&lt;0.001\n\n\n\n1 Mean (SD); n (%)\n\n\n2 Design-based KruskalWallis test; Pearson’s X^2: Rao & Scott adjustment"
  },
  {
    "objectID": "quarto/index.html#outcomes-table",
    "href": "quarto/index.html#outcomes-table",
    "title": "Clinical Outcomes of MS in CVD",
    "section": "Outcomes Table:",
    "text": "Outcomes Table:\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOverall N = 2,697,2851\nCVD with MS N = 9,5351\nCVD without MS N = 2,687,7501\np-value2\n\n\n\n\nDied during hospitalization\n137,625 (5.1)\n305 (3.2)\n137,320 (5.1)\n&lt;0.001\n\n\nLength of stay (days)\n6 (9)\n6 (8)\n6 (9)\n0.018\n\n\nInflation-adjusted total charge ($)\n84,342 (125,922)\n79,802 (103,303)\n84,358 (125,995)\n0.72\n\n\n\n1 n (%); Mean (SD)\n\n\n2 Pearson’s X^2: Rao & Scott adjustment; Design-based KruskalWallis test"
  },
  {
    "objectID": "quarto/index.html#multivariable-logistic-regression",
    "href": "quarto/index.html#multivariable-logistic-regression",
    "title": "Clinical Outcomes of MS in CVD",
    "section": "Multivariable Logistic Regression:",
    "text": "Multivariable Logistic Regression:\n\nAll-Cause Mortality:\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nOR (95% CI)1\np-value\n\n\n\n\nCVD categories\n\n\n\n\n\n\n    CVD with MS\n—\n\n\n\n\n    CVD without MS\n1.46 (1.12 to 1.90)\n0.005\n\n\nAge, y\n1.02 (1.02 to 1.02)\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n    Female\n—\n\n\n\n\n    Male\n0.96 (0.94 to 0.99)\n0.005\n\n\nRace\n\n\n\n\n\n\n    White\n—\n\n\n\n\n    Asian or Pacific Islander\n1.35 (1.26 to 1.45)\n&lt;0.001\n\n\n    Black\n0.94 (0.90 to 0.98)\n0.002\n\n\n    Hispanic\n1.08 (1.02 to 1.14)\n0.005\n\n\n    Native American\n1.02 (0.84 to 1.24)\n0.82\n\n\n    Other\n1.35 (1.25 to 1.45)\n&lt;0.001\n\n\nCharlson comorbidity index\n1.13 (1.12 to 1.14)\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n    $1 - $51,999\n—\n\n\n\n\n    $52,000 - $65,999\n0.92 (0.89 to 0.96)\n&lt;0.001\n\n\n    $66,000 - $87,999\n0.87 (0.83 to 0.91)\n&lt;0.001\n\n\n    $88,000 or more\n0.87 (0.83 to 0.91)\n&lt;0.001\n\n\nExpected primary payer\n\n\n\n\n\n\n    Private\n—\n\n\n\n\n    Medicaid\n1.10 (1.04 to 1.16)\n&lt;0.001\n\n\n    Medicare\n0.84 (0.80 to 0.88)\n&lt;0.001\n\n\n    Other\n1.68 (1.51 to 1.86)\n&lt;0.001\n\n\nHospital region\n\n\n\n\n\n\n    Midwest\n—\n\n\n\n\n    Northeast\n1.19 (1.11 to 1.26)\n&lt;0.001\n\n\n    South\n1.08 (1.03 to 1.14)\n0.002\n\n\n    West\n1.28 (1.20 to 1.35)\n&lt;0.001\n\n\nHospital bedsize\n\n\n\n\n\n\n    Large\n—\n\n\n\n\n    Medium\n0.78 (0.74 to 0.81)\n&lt;0.001\n\n\n    Small\n0.61 (0.57 to 0.65)\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n    Rural\n—\n\n\n\n\n    Urban, non-teaching\n0.95 (0.88 to 1.04)\n0.26\n\n\n    Urban, teaching\n1.45 (1.35 to 1.55)\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.58 (0.56 to 0.60)\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.64 (0.62 to 0.66)\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.64 (0.61 to 0.67)\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n1.29 (1.25 to 1.34)\n&lt;0.001\n\n\nChronic kidney disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.86 (0.83 to 0.89)\n&lt;0.001\n\n\n\n1 OR = Odds Ratio, CI = Confidence Interval"
  },
  {
    "objectID": "quarto/index.html#multivariable-linear-regression",
    "href": "quarto/index.html#multivariable-linear-regression",
    "title": "Clinical Outcomes of MS in CVD",
    "section": "Multivariable Linear Regression:",
    "text": "Multivariable Linear Regression:\n\nLength of Stay:\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nexp(Beta) (95% CI)1\np-value\n\n\n\n\nCVD categories\n\n\n\n\n\n\n    CVD with MS\n—\n\n\n\n\n    CVD without MS\n0.87 (0.61 to 1.22)\n0.42\n\n\nAge, y\n0.98 (0.98 to 0.98)\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n    Female\n—\n\n\n\n\n    Male\n1.14 (1.09 to 1.20)\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n    White\n—\n\n\n\n\n    Asian or Pacific Islander\n4.25 (3.48 to 5.19)\n&lt;0.001\n\n\n    Black\n4.06 (3.66 to 4.49)\n&lt;0.001\n\n\n    Hispanic\n2.35 (2.07 to 2.66)\n&lt;0.001\n\n\n    Native American\n1.37 (0.96 to 1.95)\n0.084\n\n\n    Other\n4.62 (3.73 to 5.72)\n&lt;0.001\n\n\nCharlson comorbidity index\n1.20 (1.18 to 1.23)\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n    $1 - $51,999\n—\n\n\n\n\n    $52,000 - $65,999\n0.95 (0.88 to 1.03)\n0.19\n\n\n    $66,000 - $87,999\n0.92 (0.84 to 1.00)\n0.056\n\n\n    $88,000 or more\n0.96 (0.86 to 1.08)\n0.50\n\n\nExpected primary payer\n\n\n\n\n\n\n    Private\n—\n\n\n\n\n    Medicaid\n9.22 (7.87 to 10.8)\n&lt;0.001\n\n\n    Medicare\n0.97 (0.90 to 1.04)\n0.39\n\n\n    Other\n0.82 (0.69 to 0.98)\n0.031\n\n\nHospital region\n\n\n\n\n\n\n    Midwest\n—\n\n\n\n\n    Northeast\n1.53 (1.29 to 1.83)\n&lt;0.001\n\n\n    South\n1.32 (1.16 to 1.50)\n&lt;0.001\n\n\n    West\n1.13 (0.96 to 1.32)\n0.14\n\n\nHospital bedsize\n\n\n\n\n\n\n    Large\n—\n\n\n\n\n    Medium\n0.48 (0.42 to 0.54)\n&lt;0.001\n\n\n    Small\n0.37 (0.31 to 0.43)\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n    Rural\n—\n\n\n\n\n    Urban, non-teaching\n0.93 (0.76 to 1.12)\n0.43\n\n\n    Urban, teaching\n2.18 (1.85 to 2.57)\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.90 (0.82 to 0.99)\n0.037\n\n\nDiabetes mellitus\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.71 (0.66 to 0.75)\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n0.44 (0.41 to 0.47)\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n3.23 (2.99 to 3.50)\n&lt;0.001\n\n\nChronic kidney disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n1.12 (1.03 to 1.22)\n0.008\n\n\n\n1 CI = Confidence Interval\n\n\n\n\n\n\n\n\n\n\nInflation Adjusted Total Charge:\n\n\n\n\n\n\n\n\n\n\n\n\n\nCharacteristic\nBeta (95% CI)1\np-value\n\n\n\n\nCVD categories\n\n\n\n\n\n\n    CVD with MS\n—\n\n\n\n\n    CVD without MS\n8,655 (3,917 to 13,394)\n&lt;0.001\n\n\nAge, y\n-979 (-1,033 to -925)\n&lt;0.001\n\n\nSex\n\n\n\n\n\n\n    Female\n—\n\n\n\n\n    Male\n-2,097 (-2,823 to -1,371)\n&lt;0.001\n\n\nRace\n\n\n\n\n\n\n    White\n—\n\n\n\n\n    Asian or Pacific Islander\n22,830 (18,167 to 27,494)\n&lt;0.001\n\n\n    Black\n8,224 (6,223 to 10,226)\n&lt;0.001\n\n\n    Hispanic\n27,699 (24,104 to 31,294)\n&lt;0.001\n\n\n    Native American\n-10,061 (-15,315 to -4,807)\n&lt;0.001\n\n\n    Other\n32,494 (27,882 to 37,105)\n&lt;0.001\n\n\nCharlson comorbidity index\n4,866 (4,573 to 5,159)\n&lt;0.001\n\n\nResidential income\n\n\n\n\n\n\n    $1 - $51,999\n—\n\n\n\n\n    $52,000 - $65,999\n451 (-1,038 to 1,941)\n0.55\n\n\n    $66,000 - $87,999\n54 (-1,855 to 1,963)\n0.96\n\n\n    $88,000 or more\n6,532 (3,688 to 9,376)\n&lt;0.001\n\n\nExpected primary payer\n\n\n\n\n\n\n    Private\n—\n\n\n\n\n    Medicaid\n15,674 (13,372 to 17,977)\n&lt;0.001\n\n\n    Medicare\n1,088 (-216 to 2,391)\n0.10\n\n\n    Other\n49 (-3,171 to 3,269)\n0.98\n\n\nHospital region\n\n\n\n\n\n\n    Midwest\n—\n\n\n\n\n    Northeast\n22,755 (18,024 to 27,486)\n&lt;0.001\n\n\n    South\n15,445 (12,804 to 18,085)\n&lt;0.001\n\n\n    West\n41,776 (37,321 to 46,231)\n&lt;0.001\n\n\nHospital bedsize\n\n\n\n\n\n\n    Large\n—\n\n\n\n\n    Medium\n-15,492 (-18,776 to -12,209)\n&lt;0.001\n\n\n    Small\n-26,168 (-29,656 to -22,680)\n&lt;0.001\n\n\nHospital location and teaching status\n\n\n\n\n\n\n    Rural\n—\n\n\n\n\n    Urban, non-teaching\n26,881 (23,701 to 30,062)\n&lt;0.001\n\n\n    Urban, teaching\n43,840 (41,678 to 46,003)\n&lt;0.001\n\n\nHypertension\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-8,743 (-10,377 to -7,108)\n&lt;0.001\n\n\nDiabetes mellitus\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-14,146 (-15,149 to -13,142)\n&lt;0.001\n\n\nPeripheral vascular disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-8,535 (-9,714 to -7,355)\n&lt;0.001\n\n\nHeart failure\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n10,417 (9,290 to 11,543)\n&lt;0.001\n\n\nChronic kidney disease\n\n\n\n\n\n\n    No\n—\n\n\n\n\n    Yes\n-9,164 (-10,359 to -7,969)\n&lt;0.001\n\n\n\n1 CI = Confidence Interval"
  }
]